Disc Medicine's rare disease drug succeeds in late-stage trial | Reuters

Disc Medicine's erythropoietic protoporphyria drug succeeds in late-stage trial

Disc Medicine's experimental pill for erythropoietic protoporphyria, a rare disease causing extreme pain from sunlight, met all primary and secondary goals in a late-stage trial, sending shares surging.